What is Survodutide?
Survodutide is a dual GLP-1/glucagon receptor agonist. The Phase 2 obesity trial published by le Roux et al. in Lancet Diabetes & Endocrinology (2024, DOI:10.1016/S2213-8587(23)00356-X) and the Phase 3 SYNCHRONIZE program (ClinicalTrials.gov) provide metabolic outcome context.
Research-catalog peptides differ from pharmaceutical formulations with respect to manufacturing controls and regulatory pathways. Laboratories sourcing research-grade survodutide must verify vendor documentation matches assay requirements.
Research areas & preclinical findings
Dual GLP-1/glucagon biology
Concurrent GLP-1 and glucagon receptor modulation shifts insulinotropic and energy-expenditure endpoints compared with GLP-1-only agonists—literature stratifies outcomes by baseline covariates.
Phase 2 and Phase 3 trial literature
The Phase 2 obesity trial and Phase 3 SYNCHRONIZE program anchor metabolic discussions; laboratory procurement references those datasets only when assay endpoints mirror trial biomarkers.
Assay translation considerations
In vitro binding assays must define receptor panels carefully—dual agonism may saturate differently than monotherapy controls.
Published research (selection)
| Study | Journal | Year | DOI | Finding (summary) |
|---|---|---|---|---|
| Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial | Lancet Diabetes Endocrinol | 2024 | link | Phase 2 obesity endpoints—trial populations differ from bench experiments. |
Important Disclaimer
All products and information on this page are intended strictly for laboratory and scientific research use only. Not for human consumption. These statements have not been evaluated by the FDA.
Quality & documentation
Dual-agonist documentation should evidence purity and identity suitable for receptor-binding assays; verify endotoxin limits if cellular assays demand sterility controls.
Storage & reconstitution (laboratory protocol)
- Follow vendor stability bulletins.
- Align storage with institutional peptide SOP.
- Cross-check calculator outputs before dilution.
Use the research peptide stock solution calculator to translate mass and concentration targets into documented laboratory volumes.
Where to source for research
Compare vendor documentation on the retailer matrix; see partner codes for checkout context.
| Vendor | List context | COA signal | Code |
|---|
Disclosure: This page contains affiliate links. We may earn from qualifying purchases. See our full disclosure.
Related research compounds
Reviewed by Dr. Marcus Webb, Ph.D.· Last reviewed May 2026